metanomics Health applies metabolite profiling to develop tools and solutions for drug discovery and development, diagnostics and nutritional research. metanomics Health develops and utilizes the technology of metanomics GmbH which is one of the largest and most innovative mass-spectrometry based metabolite profiling companies worldwide.

Metabolite profiling (or metabolomics) enables the measurement of a wide range of metabolites, including unknown compounds and novel small molecules. Using innovative bioinformatics and data mining tools metabolite profiling data integrated with other data is the basis for system wide interpretation of complex biological functions, responses or regulations.

metanomics Health cooperates with leading pharmaceutical and diagnostic companies to support and accelerate decision making in different phases of drug development, and to develop new diagnostics.

Please visit our partner website: metanomics 		metanomics Health participates in the following upcoming conferences and events:


  • CHI Tri-Conference 2010, February 3-5th, 2010, San Francisco, CA, USA
    Tri-Conference
  • Metabolomics & More, March 10-12th, 2010, Freising-Weihenstephan, Germany
    Metabolomics & More
  • 49th Annual Meeting & ToxExpo, March 7-11th, 2010, Salt Lake City, UT, USA
    SOT 2010




Please contact us if you would like to arrange a meeting during one of these conferences.